Cargando…

Long-Term Change in Renal Function After Intravitreal Anti-VEGF Treatment for Diabetic Macular Edema: A 2-Year Retrospective Cohort Study

INTRODUCTION: To investigate the longitudinal changes in renal function and associated factors after intravitreal anti-vascular endothelial growth factor (VEGF) administration in diabetic macular edema (DME). METHODS: A total of 108 patients who had received intravitreal ranibizumab or aflibercept f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Yi-Chung, Lai, Ivan Pochou, Lai, Tso-Ting, Chen, Ta-Ching, Yang, Chang-Hao, Ho, Tzyy-Chang, Yang, Chung-May, Hsieh, Yi-Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640545/ https://www.ncbi.nlm.nih.gov/pubmed/37589931 http://dx.doi.org/10.1007/s40123-023-00771-4

Ejemplares similares

Renal Biomarkers for Treatment Effect of Ranibizumab for Diabetic Macular Edema
por: Lai, Ivan Pochou, et al.
Publicado: (2020)

Treat-and-Extend vs. Pro Re Nata Regimen of Ranibizumab for Diabetic Macular Edema—A Two-Year Matched Comparative Study
por: Lai, Tso-Ting, et al.
Publicado: (2022)

Biomarkers of optical coherence tomography in evaluating the treatment outcomes of neovascular age-related macular degeneration: a real-world study
por: Lai, Tso-Ting, et al.
Publicado: (2019)

Clinical characteristics and long-term evolution of lamellar macular hole in high myopia
por: Hsia, Yun, et al.
Publicado: (2020)

Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy
por: Huang, Chu-Hsuan, et al.
Publicado: (2021)

Combined quantitative and qualitative optical coherence tomography angiography biomarkers for predicting active neovascular age-related macular degeneration
por: Hsu, Cherng-Ru, et al.
Publicado: (2021)

The impact of retinal fluid tolerance on the outcomes of neovascular age-related macular degeneration treated using aflibercept: A real-world study
por: Jeng, Yu-Ting, et al.
Publicado: (2022)

Full-thickness macular hole formation in proliferative diabetic retinopathy
por: Tsui, Mei-Chi, et al.
Publicado: (2021)

A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment
por: Hsieh, Tsung-Cheng, et al.
Publicado: (2023)

Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
por: Garoon, Robert B., et al.
Publicado: (2016)

Baseline predictors for good visual gains after anti-vascular endothelial growth factor therapy for myopic choroidal neovascularization
por: Hsu, Cherng-Ru, et al.
Publicado: (2022)

Spontaneous resolution of foveal detachment in traction maculopathy in high myopia unrelated to posterior vitreous detachment
por: Lai, Tso-Ting, et al.
Publicado: (2016)

Intravitreal Aflibercept as a Rescue Therapy for Retinal Neovascularization and Macular Edema due to Eales Disease
por: Hsia, Ning-Yi, et al.
Publicado: (2021)

Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal choroidal vasculopathy
por: Ma, I-Hsin, et al.
Publicado: (2021)

Therapeutic effect of simultaneous intravitreal dexamethasone and aflibercept on diabetic macular edema
por: Lin, Tai-Chi, et al.
Publicado: (2021)

Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment
por: Chang, Yu-Shan, et al.
Publicado: (2019)

Multimodel Imaging Evidence of Traction Component in Lamellar Macular Hole with Epiretinal Proliferation
por: Su, Yu-Ting, et al.
Publicado: (2023)

Intravitreal aflibercept combined with transpupillary thermotherapy in the treatment of refractory macular edema due to primary uveal melanoma
por: Huang, Yu-Te, et al.
Publicado: (2022)

Risk of renal damage associated with intravitreal anti-VEGF therapy for diabetic macular edema in routine clinical practice
por: del Cura, Mar Prieto, et al.
Publicado: (2023)

Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
por: Koc, Hakan, et al.
Publicado: (2023)

Vitrectomy with internal limiting membrane peeling versus nonsurgical treatment for diabetic macular edema with massive hard exudates
por: Lin, Hsuan-Chieh, et al.
Publicado: (2020)

Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion
por: Tsai, Meng-Ju, et al.
Publicado: (2018)

Comparison of Intravitreal Dexamethasone Implant and Ranibizumab in Vitrectomized Eyes with Diabetic Macular Edema
por: Wang, Jia-Kang, et al.
Publicado: (2021)

Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
por: Chiu, Chiung-Yi, et al.
Publicado: (2021)

The Clinical Contribution of Full-Field Electroretinography and 8-Year Experiences of Application in a Tertiary Medical Center
por: Yang, Jung-Je, et al.
Publicado: (2021)

Clinical features and prognosis of polypoidal choroidal vasculopathy with different morphologies of branching vascular network on optical coherence tomography angiography
por: Ma, Shang-Te, et al.
Publicado: (2021)

INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: Pharmacokinetic Considerations
por: Yang, Yit, et al.
Publicado: (2015)

Real-World Evidence in the Management of Diabetic Macular Edema with Intravitreal Anti-VEGFs in Asia: A Systematic Literature Review
por: Yuen, Yew Sen, et al.
Publicado: (2022)

Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion
por: Bae, Young Hwan, et al.
Publicado: (2021)

Synergistic Effect of Combined Sub-Tenon Triamcinolone and Intravitreal Anti-VEGF Therapy for Uveitic Macular Edema
por: Lin, Dan, et al.
Publicado: (2022)

Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection
por: Hong, Eun Hee, et al.
Publicado: (2022)

Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
por: Yoon, Chang Ki, et al.
Publicado: (2021)

Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
por: Seo, Jeong Won, et al.
Publicado: (2009)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Intravitreal Therapy for Diabetic Macular Edema: An Update
por: Furino, Claudio, et al.
Publicado: (2021)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFs
por: Bakbak, Berker, et al.
Publicado: (2016)

Combined Intravitreal Dexamethasone Implant And Micropulse Yellow Laser For Treatment Of Anti-VEGF Resistant Diabetic Macular Edema
por: Elhamid, Ahmed Hosni Abd
Publicado: (2017)

The effect of insulin on response to intravitreal anti-VEGF injection in diabetic macular edema in type 2 diabetes mellitus
por: Gurung, Rajya L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7e7mn1ef670sumqumhmiur2jis